Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain
about
Biological significance of agmatine, an endogenous ligand at imidazoline binding sitesPharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.Imidazoline receptors and human brain disorders.Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptorsModulation of stress by imidazoline binding sites: implications for psychiatric disorders.Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence.Localization of I2-imidazoline binding sites on monoamine oxidases.Imidazoline binding sites. Pharmacological and molecular characteristics.Functional studies of specific imidazoline-2 receptor ligands.I2-imidazoline receptors in the healthy and pathologic human brain.Imidazolines stimulate release of insulin from RIN-5AH cells independently from I1- and I2-imidazoline receptors.Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.Involvement of I1-imidazoline receptors in mood disorders.Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studiesThe imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands.Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.Lack of effect of reserpine on immunoreactive imidazoline receptor proteins in rat brain.
P2860
Q24673628-140265D1-DDD8-4109-995F-3E643BC3D450Q33693033-5725DFB5-CE5C-4D65-BE5D-E94A8C2D96D4Q33693078-F824C27E-2C9F-480D-8E48-978B9052C165Q35026368-1A8A2F34-6EBF-49E4-B416-061228D612F3Q35872992-9E3324C0-624C-453C-82AA-F987C2315542Q35873028-B2432517-78CC-4507-AB29-88CF552324EAQ37324414-849CE3C6-B7B9-44DB-9973-5C2227035E10Q38617975-931D2278-D3F8-416D-9870-59A22A9E6CDCQ39379564-E6A76866-7448-434E-8C2D-F9FA1C897E39Q40483859-3BF059B6-87FE-4FE1-98D6-882B2D60BC46Q40483870-DB66EAB2-7BCC-44BD-8900-807D6A603C80Q40483894-253E4704-81E4-456D-BB20-5C0BFC4C3881Q40483951-95D1394D-F3CA-4FAE-B360-6918D6B62F88Q40483957-275C79FE-A1E9-421D-AB15-99098D7146D6Q40483977-0A4215DD-444F-4A8C-B140-B15BFF800895Q41835100-5813C923-D2E0-483C-9D3D-EB82A9CF95E9Q41861525-794CB06D-3FCD-45E0-8261-D39C9FE3B69BQ41984937-00A9790C-FFB5-4F31-8AAB-CCCC1C68B768Q42069216-33282568-3112-44E7-8EA6-4496CDEC563DQ42273906-E8D5DD58-D094-4F22-81FD-D30204108572Q42701372-86006CED-769B-4782-9A94-81949BC91E73Q43262083-F0F0FE37-928F-446E-90AE-AF5CF7BEA985Q43264170-AE07280A-9203-42A5-AEB4-77D3870BB629Q44372626-555F4382-67AC-4763-80B0-5D69E1FC5BC0Q48155205-F1E5BAD5-C031-48C5-ABF2-7BDA089727FCQ48155212-60EFE46D-6F16-4ACB-A90B-C76734FDDEC8Q48155223-FB68EEB5-E6BA-4A16-9665-ACEE0B9E1DFDQ48155274-7C1D891F-FB20-4D18-954D-2CFD5E9737F5
P2860
Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Chronic treatment with the mon ...... binding sites in the rat brain
@ast
Chronic treatment with the mon ...... binding sites in the rat brain
@en
type
label
Chronic treatment with the mon ...... binding sites in the rat brain
@ast
Chronic treatment with the mon ...... binding sites in the rat brain
@en
prefLabel
Chronic treatment with the mon ...... binding sites in the rat brain
@ast
Chronic treatment with the mon ...... binding sites in the rat brain
@en
P2860
P50
P1476
Chronic treatment with the mon ...... binding sites in the rat brain
@en
P2093
J A García-Sevilla
P2860
P304
P356
10.1111/J.1476-5381.1993.TB12848.X
P407
P577
1993-03-01T00:00:00Z